Ethacrynic acid NDC 52817-367

NDC codes

FDA NDC Directory

Product NDC (as listed)52817-367Labeler and product segments. Claims need a package NDC.

Product NDC at billing width52817-0367Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
52817-367-10	52817036710	100 TABLET in 1 BOTTLE (52817-367-10)Marketed from Sep 12, 2019
52817-367-90	52817036790	90 TABLET in 1 BOTTLE (52817-367-90)Marketed from Sep 12, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ethacrynic acid
Generic name (nonproprietary): ethacrynic acid
Active ingredients: Ethacrynic acid — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: TRUPHARMA LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211809
Marketing start: Sep 12, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Increased Diuresis at Loop of Henle (Physiologic effect)
Identifiers: Product ID 52817-367_fb026274-f2ff-4316-adcf-2590aabf5a76SPL ID fb026274-f2ff-4316-adcf-2590aabf5a76SPL set ID 3b2b6ee1-1859-4b02-9ef2-5bbe6427f61aRxCUI 1251903UNII M5DP350VZVUPC 0352817367907, 0352817367105
Pharmacologic class: Loop Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N452817036710 followed by a unit qualifier and the quantity

Package 52817-0367-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 1, 2025.

Indications (excerpt from the label)

INDICATIONS & USAGE Ethacrynic Acid Tablets USP, are indicated for treatment of edema when an agent with greater diuretic potential than those commonly employed is required. Treatment of the edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Short-term management of ascites due to malignancy, idiopathic edema, and lymphedema. Short-term management of hospitalized pediatric patients, other than infants, with congenital heart disease or the nephrotic syndrome. Intravenous ethacrynate sodium is indicated when a rapid onset of diuresis is desired, e.g., in acute pulmonary edema, or when gastrointestinal absorption is impai…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)